Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years ...

Saphenous vein graft failure remains a persistent clinical problem following coronary artery bypass grafting (CABG).  In the NEWTON-CABG CardioLink-5 trial, cholesterol-lowering with evolocumab did ...

Meeting Coverage > STS Bypass Surgery for Multivessel CAD Reaffirmed in Newer Data — Surgeons fire back at downgrading of CABG in recent guidelines by Nicole Lou, Senior Staff Writer, MedPage ...

Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year ...

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis But the 3-year analysis presented here this week at EuroPCR 2024 by Frederik M. Zimmermann, MD, PhD ...

Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers at ...

Dual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular ...

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone – and it increases the risk of ...